🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/01/2006 | 31,60 | 31,89 | 31,44 | 31,52 | -0,54% | 1,42% | 9.579.978 |
| 17/01/2006 | 31,59 | 32,11 | 31,50 | 31,69 | -0,78% | 1,93% | 10.750.489 |
| 13/01/2006 | 31,99 | 32,18 | 31,82 | 31,94 | -0,03% | 1,10% | 7.420.259 |
| 12/01/2006 | 32,02 | 32,04 | 31,82 | 31,95 | +0,06% | 0,69% | 7.491.733 |
| 11/01/2006 | 31,96 | 32,05 | 31,78 | 31,93 | +0,39% | 0,84% | 10.005.570 |
| 10/01/2006 | 31,92 | 31,92 | 31,61 | 31,80 | -0,98% | 0,96% | 9.410.411 |
| 09/01/2006 | 31,70 | 32,12 | 31,25 | 32,12 | +1,63% | 2,74% | 16.702.919 |
| 06/01/2006 | 31,57 | 31,83 | 31,36 | 31,60 | -0,18% | 1,48% | 9.776.058 |
| 05/01/2006 | 31,41 | 31,86 | 31,01 | 31,66 | +0,15% | 2,70% | 16.383.908 |
| 04/01/2006 | 31,25 | 31,68 | 31,25 | 31,61 | +1,16% | 1,37% | 13.149.466 |
| 03/01/2006 | 31,03 | 31,36 | 30,35 | 31,25 | +2,95% | 3,26% | 12.185.725 |
| 30/12/2005 | 30,87 | 30,87 | 30,31 | 30,35 | -1,67% | 1,82% | 8.693.160 |
| 29/12/2005 | 30,61 | 31,05 | 30,61 | 30,87 | +1,38% | 1,43% | 8.017.724 |
| 28/12/2005 | 30,57 | 30,72 | 30,34 | 30,45 | -0,09% | 1,22% | 6.786.114 |
| 27/12/2005 | 30,63 | 30,76 | 30,35 | 30,48 | -0,81% | 1,34% | 6.671.778 |
| 23/12/2005 | 30,16 | 30,76 | 30,16 | 30,73 | +0,59% | 1,99% | 5.039.727 |
| 22/12/2005 | 30,43 | 30,57 | 30,25 | 30,54 | +0,25% | 1,07% | 7.801.941 |
| 21/12/2005 | 30,67 | 30,67 | 30,37 | 30,47 | -0,19% | 0,96% | 7.721.874 |
| 20/12/2005 | 30,64 | 30,87 | 30,35 | 30,52 | -0,81% | 1,68% | 16.410.003 |
| 19/12/2005 | 29,53 | 30,82 | 29,53 | 30,77 | +7,46% | 4,36% | 40.581.390 |
| 16/12/2005 | 28,24 | 28,71 | 28,24 | 28,64 | +0,81% | 1,66% | 17.402.040 |
| 15/12/2005 | 28,34 | 28,82 | 28,15 | 28,41 | +1,95% | 2,36% | 17.891.246 |
| 14/12/2005 | 27,58 | 28,40 | 27,56 | 27,86 | +1,04% | 3,04% | 16.768.314 |
| 13/12/2005 | 27,22 | 27,81 | 27,19 | 27,58 | +1,72% | 2,28% | 13.546.134 |
| 12/12/2005 | 27,43 | 28,24 | 26,71 | 27,11 | -2,47% | 5,60% | 25.366.421 |
| 09/12/2005 | 27,69 | 27,90 | 27,44 | 27,80 | -1,85% | 1,65% | 18.691.604 |
| 08/12/2005 | 28,82 | 29,00 | 28,26 | 28,32 | -2,01% | 2,55% | 13.959.570 |
| 07/12/2005 | 28,65 | 29,11 | 28,55 | 28,90 | +0,53% | 1,96% | 9.602.300 |
| 06/12/2005 | 28,73 | 29,03 | 28,67 | 28,75 | +0,07% | 1,23% | 8.972.033 |
| 05/12/2005 | 28,41 | 28,75 | 28,34 | 28,73 | +0,47% | 1,44% | 9.492.679 |